Safety of discontinuing cotrimoxazole prophylaxis among HIV infected adults on anti-retroviral therapy in Uganda (COSTOP trial): Design

INTRODUCTION: Cotrimoxazole (CTX) prophylaxis is recommended by the World Health Organisation for HIV infected persons. However, once HIV infected patients have commenced ART in resource limited settings, the benefits of continued CTX prophylaxis are not known. The few studies that investigated the...

Descripción completa

Detalles Bibliográficos
Autores principales: Anywaine, Zacchaeus, Abaasa, Andrew, Levin, Jonathan, Kasirye, Ronnie, Kamali, Anatoli, Grosskurth, Heiner, Munderi, Paula, Nunn, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4542218/
https://www.ncbi.nlm.nih.gov/pubmed/26009024
http://dx.doi.org/10.1016/j.cct.2015.05.015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4542218/
https://www.ncbi.nlm.nih.gov/pubmed/26009024
http://dx.doi.org/10.1016/j.cct.2015.05.015

Ejemplares similares